PMVP 10-Q: SEC filing

PMV Pharmaceuticals

Filed with the SEC on Nov 10, 2026 · accession 0001193125-26-454471

PMVP filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. PMV Pharmaceuticals filed its Q3 2026 10-Q, reporting financial results and disclosing a September 2026 public offering of common stock and warrants.

Summary of the filing

PMV Pharmaceuticals filed its Q3 2026 10-Q, reporting financial results and disclosing a September 2026 public offering of common stock and warrants. The filing also includes details on an option exchange program and lease termination.

For details, click here →How to read a 10-Q →

Key details

FilerPMV Pharmaceuticals, Inc.

✦ Ask GOAX AI about this filing — what it means for PMVP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PMVP?

Click here

Frequently asked questions

What did PMVP file with the SEC on Nov 10, 2026?

PMVP filed a 10-Q (SEC filing). PMV Pharmaceuticals filed its Q3 2026 10-Q, reporting financial results and disclosing a September 2026 public offering of common stock and warrants. The filing also includes details on an option exchange program and lease termination.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other PMVP SEC filings

Get alerts when PMVP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

PMVP overview PMVP analysis PMVP news Latest SEC filings